Search research articles
Contact Us
Filters
Showing results (131-140 of 205) with videos related to
Page
of 21
Sort By:
In Vivo (Athens, Greece)
|
July 2, 2020
The ABO Blood Group Impacts the Survival of Patients Undergoing Pancreatoduodenectomy for Biliary Tract Cancer
Shozo Mori, Taku Aoki, Kazuma Tago, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
September 19, 2020
Effects of branched-chain amino acids on postoperative tumor recurrence in patients undergoing curative resection for hepatocellular carcinoma: A randomized clinical trial
Hiroyuki Hachiya, Taku Aoki, Yukihiro Iso, et al.
World Journal of Surgery
|
March 12, 2024
Comparative analysis of perioperative and long-term outcomes of patients with hepatocellular carcinoma: Nonalcoholic fatty liver disease versus viral hepatitis
Takatsugu Matsumoto, Takayuki Shiraki, Genki Tanaka, et al.
Cancer Chemotherapy and Pharmacology
|
April 7, 2021
Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma
Shozo Mori, Taku Aoki, Yuhki Sakuraoka, et al.
Lancet (London, England)
|
December 31, 2002
Pringle's manoeuvre in living donors
Hiroshi Imamura, Tadatoshi Takayama, Yasuhiko Sugawara, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
October 16, 2021
Prognostic significance of preoperative hyaluronic acid level in patients with hepatocellular carcinoma
Takatsugu Matsumoto, Taku Aoki, Takayuki Shimizu, et al.
Hepatology International
|
August 24, 2021
Volumetric assessment and clinical predictors of cirrhosis in patients undergoing hepatectomy for hepatocellular carcinoma with presumed normal liver function
Takayuki Shimizu, Taku Aoki, Kyung-Hwa Park, et al.
Pancreas
|
May 21, 2021
Predictors of Poor Pathological Response to Neoadjuvant Gemcitabine Plus S-1 Chemotherapy in Patients With Pancreatic Ductal Adenocarcinoma
Shozo Mori, Taku Aoki, Yuhki Sakuraoka, et al.
American Journal of Surgery
|
March 28, 2008
Two-stage pancreatojejunostomy in pancreaticoduodenectomy: a retrospective analysis of short-term results
Kiyoshi Hasegawa, Norihiro Kokudo, Keiji Sano, et al.
World Journal of Surgery
|
August 8, 2014
Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma
Chetana Lim, Yoshihiro Mise, Yoshihiro Sakamoto, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 205) with videos related to
Sort By:
Page
of 21
In Vivo (Athens, Greece)
|
July 2, 2020
The ABO Blood Group Impacts the Survival of Patients Undergoing Pancreatoduodenectomy for Biliary Tract Cancer
Shozo Mori, Taku Aoki, Kazuma Tago, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
September 19, 2020
Effects of branched-chain amino acids on postoperative tumor recurrence in patients undergoing curative resection for hepatocellular carcinoma: A randomized clinical trial
Hiroyuki Hachiya, Taku Aoki, Yukihiro Iso, et al.
World Journal of Surgery
|
March 12, 2024
Comparative analysis of perioperative and long-term outcomes of patients with hepatocellular carcinoma: Nonalcoholic fatty liver disease versus viral hepatitis
Takatsugu Matsumoto, Takayuki Shiraki, Genki Tanaka, et al.
Cancer Chemotherapy and Pharmacology
|
April 7, 2021
Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma
Shozo Mori, Taku Aoki, Yuhki Sakuraoka, et al.
Lancet (London, England)
|
December 31, 2002
Pringle's manoeuvre in living donors
Hiroshi Imamura, Tadatoshi Takayama, Yasuhiko Sugawara, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
October 16, 2021
Prognostic significance of preoperative hyaluronic acid level in patients with hepatocellular carcinoma
Takatsugu Matsumoto, Taku Aoki, Takayuki Shimizu, et al.
Hepatology International
|
August 24, 2021
Volumetric assessment and clinical predictors of cirrhosis in patients undergoing hepatectomy for hepatocellular carcinoma with presumed normal liver function
Takayuki Shimizu, Taku Aoki, Kyung-Hwa Park, et al.
Pancreas
|
May 21, 2021
Predictors of Poor Pathological Response to Neoadjuvant Gemcitabine Plus S-1 Chemotherapy in Patients With Pancreatic Ductal Adenocarcinoma
Shozo Mori, Taku Aoki, Yuhki Sakuraoka, et al.
American Journal of Surgery
|
March 28, 2008
Two-stage pancreatojejunostomy in pancreaticoduodenectomy: a retrospective analysis of short-term results
Kiyoshi Hasegawa, Norihiro Kokudo, Keiji Sano, et al.
World Journal of Surgery
|
August 8, 2014
Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma
Chetana Lim, Yoshihiro Mise, Yoshihiro Sakamoto, et al.
Page
of 21